ホームページ Cytoskeletal Signaling Cardiac Myosin

Cardiac Myosin

Cardiac Myosin製品

  • All (3)
  • Cardiac Myosin阻害剤 (2)
  • Cardiac Myosin活性剤(1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S9948 Danicamtiv (MYK-491) Danicamtiv (MYK-491, SAR 440181) is a novel cardiac myosin activator that enhances cardiomyocyte contraction.
bioRxiv, 2024, 2024.10.09.617269
J Am Heart Assoc, 2023, 12(20):e030682
E4662New CK-586 CK-586(CK-4021586) is an inhibitor of cardiac myosin used to treat obstructive hypertrophic cardiomyopathy (oHCM). It effectively reduces left ventricular outflow tract obstruction (LVOTO) in a dose-dependent manner.
E1016 Aficamten (CK-274) Aficamten (CK-274, CK 3773274) is a novel cardiac myosin inhibitor that reduces myocardial contractility in vitro and in vivo with an IC50 of 1.4 μM.
E4662New CK-586 CK-586(CK-4021586) is an inhibitor of cardiac myosin used to treat obstructive hypertrophic cardiomyopathy (oHCM). It effectively reduces left ventricular outflow tract obstruction (LVOTO) in a dose-dependent manner.
E1016 Aficamten (CK-274) Aficamten (CK-274, CK 3773274) is a novel cardiac myosin inhibitor that reduces myocardial contractility in vitro and in vivo with an IC50 of 1.4 μM.
S9948 Danicamtiv (MYK-491) Danicamtiv (MYK-491, SAR 440181) is a novel cardiac myosin activator that enhances cardiomyocyte contraction.
bioRxiv, 2024, 2024.10.09.617269
J Am Heart Assoc, 2023, 12(20):e030682
E4662New CK-586 CK-586(CK-4021586) is an inhibitor of cardiac myosin used to treat obstructive hypertrophic cardiomyopathy (oHCM). It effectively reduces left ventricular outflow tract obstruction (LVOTO) in a dose-dependent manner.

Cardiac Myosin阻害剤の選択性比較

Tags: Cardiac Myosin inhibitor|Cardiac Myosin agonist|Cardiac Myosin activator|Cardiac Myosin inducer|Cardiac Myosin antagonist|Cardiac Myosin signaling pathway|Cardiac Myosin assay kit